Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy-Reference-Cited by-同舟云学术

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy

Published:2007-06-05 Issue:4 Volume:8 Page:278-288
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Ruzzo A,Graziano F,Loupakis F,Santini D,Catalano V,Bisonni R,Ficarelli R,Fontana A,Andreoni F,Falcone A,Canestrari E,Tonini G,Mari D,Lippe P,Pizzagalli F,Schiavon G,Alessandroni P,Giustini L,Maltese P,Testa E,Menichetti E T,Magnani M

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/6500463.pdf

Reference54 articles.

1. Kelly H, Goldberg RM . Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 2005; 23: 4553–4560.

2. Colucci G, Gebbia V, Paoletti G, Giuliani F, Caruso M, Gebbia N et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 2005; 23: 4866–4875.

3. Marsh S, McLeod HL . Cancer pharmacogenetics. Br J Cancer 2004; 90: 8–11.

4. Marsh S, McLeod HL . Pharmacogenetics of irinotecan toxicity. Pharmacogenomics 2004; 5: 835–843.

5. Popat S, Matakidou A, Houlston RS . Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2004; 22: 529–536.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis revisiting the influence of UGT1A1*28 and UGT1A1*6 on irinotecan safety in colorectal cancer patients;Pharmacogenomics;2024-08-22

2. Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer;International Journal of Molecular Sciences;2023-12-20

3. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited;Cancers;2023-01-06

4. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity;Methods in Molecular Biology;2022

5. C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancer;Pharmacogenetics and Genomics;2021-06-09